
Opinion|Videos|June 24, 2024
The Pathophysiology of Hidradenitis Suppurativa
Author(s)Iltefat Hamzavi, MD
Iltefat Hamzavi, MD, describes the pathophysiology of hidradenitis suppurativa and associated comorbidities that are commonly seen in patients.
Advertisement
Episodes in this series

Video content above is prompted by the following question(s):
- What is the pathophysiology of hidradenitis suppurativa (HS) and are there any risk factors for being affected by this disease?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL
2
Emerging Breakthroughs in Neurodegenerative Disease Treatments: Kavita Nair, PhD, FAAN
3
Ibrutinib-Based Frontline Regimens Narrow the Survival Gap in CLL
4
Global CKD Burden Nearly Doubles Since 1990, Reaching 788 Million Adults Worldwide
5
















































